ESR1 and breast cancer: Indeed, pCR rates remain low in patients with LABC, especially those patients who have ER +/Her2- disease, i.e. the majority of breast cancer patients (Kuerer et al. 1999; Guarneri et al. 2006; Liu et al. 2010).